 Claudia Staab-Weijnitz
Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial Cells | 11 | 2026 | 1126 | 2.940 |
Why?
| | Idiopathic Pulmonary Fibrosis | 11 | 2026 | 691 | 2.860 |
Why?
| | Bronchi | 6 | 2026 | 267 | 2.640 |
Why?
| | Respiratory Mucosa | 5 | 2026 | 322 | 2.560 |
Why?
| | Tacrolimus Binding Proteins | 5 | 2022 | 26 | 1.900 |
Why?
| | Pulmonary Fibrosis | 6 | 2024 | 395 | 1.460 |
Why?
| | Collagen | 4 | 2026 | 456 | 1.130 |
Why?
| | Collagen Type I | 3 | 2026 | 147 | 1.050 |
Why?
| | Fibroblasts | 9 | 2026 | 1034 | 1.050 |
Why?
| | Cell Differentiation | 6 | 2026 | 2050 | 0.980 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2026 | 27 | 0.960 |
Why?
| | Lung | 11 | 2025 | 4109 | 0.950 |
Why?
| | Extracellular Matrix Proteins | 3 | 2023 | 159 | 0.910 |
Why?
| | Protein Processing, Post-Translational | 2 | 2026 | 477 | 0.880 |
Why?
| | Cell Nucleus | 2 | 2025 | 619 | 0.830 |
Why?
| | Regeneration | 1 | 2025 | 197 | 0.800 |
Why?
| | Cholesterol | 1 | 2025 | 408 | 0.790 |
Why?
| | Neoplasm Proteins | 1 | 2026 | 444 | 0.760 |
Why?
| | DNA-Binding Proteins | 2 | 2026 | 1500 | 0.700 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2025 | 531 | 0.680 |
Why?
| | Lung Diseases | 2 | 2025 | 787 | 0.610 |
Why?
| | Extracellular Matrix | 4 | 2025 | 553 | 0.560 |
Why?
| | Collagen Type VI | 1 | 2018 | 5 | 0.560 |
Why?
| | Cells, Cultured | 6 | 2026 | 4155 | 0.540 |
Why?
| | Fibrillar Collagens | 1 | 2017 | 14 | 0.530 |
Why?
| | Smoking | 2 | 2021 | 1472 | 0.500 |
Why?
| | Glutathione Peroxidase | 1 | 2016 | 39 | 0.490 |
Why?
| | Models, Biological | 2 | 2021 | 1822 | 0.480 |
Why?
| | Drug Repositioning | 1 | 2016 | 41 | 0.480 |
Why?
| | Pyridones | 1 | 2017 | 199 | 0.460 |
Why?
| | Cell Movement | 3 | 2018 | 965 | 0.440 |
Why?
| | Up-Regulation | 5 | 2024 | 852 | 0.430 |
Why?
| | Bronchopneumonia | 1 | 2014 | 6 | 0.420 |
Why?
| | Glutaredoxins | 1 | 2014 | 15 | 0.410 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2016 | 381 | 0.410 |
Why?
| | fas Receptor | 1 | 2014 | 92 | 0.400 |
Why?
| | Indoles | 1 | 2017 | 501 | 0.390 |
Why?
| | Lung Diseases, Interstitial | 2 | 2017 | 660 | 0.390 |
Why?
| | Fibrosis | 5 | 2023 | 548 | 0.380 |
Why?
| | Humans | 36 | 2026 | 144957 | 0.350 |
Why?
| | Pseudomonas Infections | 1 | 2014 | 221 | 0.350 |
Why?
| | Pseudomonas aeruginosa | 1 | 2014 | 356 | 0.340 |
Why?
| | Transforming Growth Factor beta1 | 3 | 2023 | 178 | 0.330 |
Why?
| | Mice, Knockout | 4 | 2026 | 3125 | 0.330 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 3 | 2017 | 10 | 0.310 |
Why?
| | Cigarette Smoking | 2 | 2023 | 99 | 0.310 |
Why?
| | Protein Transport | 3 | 2025 | 441 | 0.260 |
Why?
| | Mice | 10 | 2026 | 18365 | 0.260 |
Why?
| | Animals | 14 | 2026 | 38109 | 0.250 |
Why?
| | Pulmonary Surfactant-Associated Protein D | 1 | 2026 | 29 | 0.240 |
Why?
| | Pulmonary Surfactant-Associated Protein A | 1 | 2026 | 29 | 0.240 |
Why?
| | Prolyl Hydroxylases | 1 | 2026 | 6 | 0.240 |
Why?
| | Hydroxylation | 1 | 2026 | 49 | 0.240 |
Why?
| | TRPV Cation Channels | 1 | 2026 | 43 | 0.240 |
Why?
| | Basement Membrane | 1 | 2025 | 32 | 0.230 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2025 | 14 | 0.230 |
Why?
| | Collagen Type IV | 1 | 2025 | 28 | 0.230 |
Why?
| | Naphthalenes | 1 | 2025 | 56 | 0.230 |
Why?
| | Airway Remodeling | 1 | 2025 | 64 | 0.220 |
Why?
| | Receptors, Purinergic P2X4 | 1 | 2024 | 6 | 0.210 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2024 | 12 | 0.210 |
Why?
| | Down-Regulation | 2 | 2017 | 627 | 0.210 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2025 | 428 | 0.210 |
Why?
| | Bleomycin | 2 | 2016 | 253 | 0.210 |
Why?
| | Myofibroblasts | 2 | 2023 | 143 | 0.210 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 923 | 0.200 |
Why?
| | Golgi Apparatus | 1 | 2024 | 100 | 0.200 |
Why?
| | Coronavirus 229E, Human | 1 | 2022 | 7 | 0.190 |
Why?
| | Proteomics | 3 | 2026 | 1195 | 0.190 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2024 | 561 | 0.180 |
Why?
| | MicroRNAs | 2 | 2023 | 701 | 0.180 |
Why?
| | Peptidylprolyl Isomerase | 1 | 2022 | 9 | 0.180 |
Why?
| | Disease Models, Animal | 6 | 2025 | 4569 | 0.180 |
Why?
| | Middle East Respiratory Syndrome Coronavirus | 1 | 2021 | 11 | 0.180 |
Why?
| | Coronavirus | 1 | 2022 | 47 | 0.180 |
Why?
| | Plasma Cells | 1 | 2022 | 79 | 0.180 |
Why?
| | TRPM Cation Channels | 1 | 2022 | 75 | 0.180 |
Why?
| | Oxidative Stress | 2 | 2019 | 1339 | 0.170 |
Why?
| | Radiation Pneumonitis | 1 | 2020 | 31 | 0.160 |
Why?
| | Mice, Inbred C57BL | 4 | 2025 | 5997 | 0.160 |
Why?
| | CRISPR-Cas Systems | 1 | 2021 | 170 | 0.160 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2024 | 370 | 0.150 |
Why?
| | Cathepsins | 1 | 2019 | 24 | 0.150 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2026 | 636 | 0.150 |
Why?
| | Apoptosis | 2 | 2026 | 2430 | 0.150 |
Why?
| | Vitamin K 3 | 2 | 2016 | 3 | 0.150 |
Why?
| | Autophagy | 1 | 2021 | 286 | 0.150 |
Why?
| | Radiation Injuries | 1 | 2020 | 151 | 0.150 |
Why?
| | Mice, Transgenic | 1 | 2024 | 2185 | 0.140 |
Why?
| | Smokers | 1 | 2019 | 137 | 0.140 |
Why?
| | Matrix Metalloproteinases, Secreted | 1 | 2018 | 12 | 0.140 |
Why?
| | S100 Calcium-Binding Protein A4 | 1 | 2018 | 4 | 0.140 |
Why?
| | Alveolar Epithelial Cells | 3 | 2026 | 120 | 0.140 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 116 | 0.130 |
Why?
| | Immunoglobulin G | 1 | 2022 | 893 | 0.130 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2017 | 6 | 0.130 |
Why?
| | Membrane Proteins | 1 | 2024 | 1167 | 0.130 |
Why?
| | Pneumonia | 1 | 2023 | 631 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2022 | 378 | 0.130 |
Why?
| | Epithelium | 1 | 2018 | 314 | 0.130 |
Why?
| | Transcription Factors | 1 | 2025 | 1742 | 0.130 |
Why?
| | Macrophage Activation | 1 | 2018 | 193 | 0.130 |
Why?
| | Skin Diseases | 1 | 2017 | 149 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 225 | 0.120 |
Why?
| | Pulmonary Alveoli | 1 | 2018 | 383 | 0.110 |
Why?
| | Caloric Restriction | 1 | 2017 | 127 | 0.110 |
Why?
| | Demography | 1 | 2016 | 288 | 0.110 |
Why?
| | Macrophages, Alveolar | 1 | 2018 | 368 | 0.110 |
Why?
| | Kidney Cortex | 1 | 2014 | 27 | 0.110 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2609 | 0.110 |
Why?
| | Kidney Medulla | 1 | 2014 | 31 | 0.110 |
Why?
| | Aging | 1 | 2025 | 1966 | 0.110 |
Why?
| | Cytokines | 2 | 2023 | 2065 | 0.100 |
Why?
| | Tobacco Products | 1 | 2015 | 84 | 0.100 |
Why?
| | Signal Transduction | 3 | 2025 | 5233 | 0.100 |
Why?
| | Smoke | 1 | 2015 | 148 | 0.100 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3415 | 0.100 |
Why?
| | S-Nitrosoglutathione | 1 | 2013 | 8 | 0.100 |
Why?
| | Proteome | 1 | 2017 | 518 | 0.090 |
Why?
| | Cell Culture Techniques | 1 | 2015 | 375 | 0.090 |
Why?
| | Antioxidants | 1 | 2016 | 549 | 0.090 |
Why?
| | Alcohol Oxidoreductases | 1 | 2013 | 62 | 0.090 |
Why?
| | Case-Control Studies | 2 | 2019 | 3608 | 0.090 |
Why?
| | Momordica charantia | 1 | 2011 | 12 | 0.090 |
Why?
| | Reperfusion Injury | 1 | 2014 | 300 | 0.090 |
Why?
| | Cysteine | 1 | 2013 | 210 | 0.090 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2016 | 1217 | 0.090 |
Why?
| | Transcription, Genetic | 1 | 2017 | 1496 | 0.080 |
Why?
| | Male | 8 | 2025 | 72406 | 0.080 |
Why?
| | Plant Extracts | 1 | 2011 | 187 | 0.080 |
Why?
| | Antiviral Agents | 2 | 2023 | 768 | 0.060 |
Why?
| | Acute Kidney Injury | 1 | 2014 | 866 | 0.060 |
Why?
| | Female | 7 | 2025 | 78376 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2023 | 2832 | 0.060 |
Why?
| | Biomarkers | 3 | 2025 | 4275 | 0.050 |
Why?
| | Aged | 4 | 2019 | 25947 | 0.050 |
Why?
| | Antineoplastic Agents | 1 | 2016 | 2197 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2738 | 0.050 |
Why?
| | Isothiocyanates | 1 | 2023 | 3 | 0.050 |
Why?
| | TRPA1 Cation Channel | 1 | 2023 | 5 | 0.050 |
Why?
| | Luciferases, Renilla | 1 | 2022 | 4 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2016 | 2642 | 0.050 |
Why?
| | Immunity | 1 | 2023 | 139 | 0.050 |
Why?
| | Fibrinolysin | 1 | 2022 | 19 | 0.050 |
Why?
| | Cyclophilins | 1 | 2022 | 40 | 0.050 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 2017 | 598 | 0.050 |
Why?
| | Plasminogen Activator Inhibitor 1 | 1 | 2022 | 84 | 0.050 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2023 | 202 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2011 | 1389 | 0.040 |
Why?
| | Fibronectins | 1 | 2022 | 136 | 0.040 |
Why?
| | Cyclosporine | 1 | 2022 | 265 | 0.040 |
Why?
| | Tacrolimus | 1 | 2022 | 196 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2025 | 629 | 0.040 |
Why?
| | Epitopes | 1 | 2023 | 485 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 336 | 0.040 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 170 | 0.040 |
Why?
| | Middle Aged | 3 | 2019 | 35928 | 0.040 |
Why?
| | Radiotherapy Dosage | 1 | 2020 | 289 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2022 | 744 | 0.040 |
Why?
| | Virus Replication | 1 | 2021 | 529 | 0.040 |
Why?
| | Niclosamide | 1 | 2018 | 2 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 371 | 0.040 |
Why?
| | Cytoprotection | 1 | 2018 | 55 | 0.030 |
Why?
| | A549 Cells | 1 | 2018 | 75 | 0.030 |
Why?
| | Oxidation-Reduction | 2 | 2013 | 1087 | 0.030 |
Why?
| | Biocatalysis | 1 | 2018 | 69 | 0.030 |
Why?
| | Protein Binding | 1 | 2024 | 2276 | 0.030 |
Why?
| | Age Factors | 1 | 2025 | 3335 | 0.030 |
Why?
| | Immunosuppressive Agents | 1 | 2022 | 847 | 0.030 |
Why?
| | Tissue Survival | 1 | 2017 | 16 | 0.030 |
Why?
| | Gene Silencing | 1 | 2018 | 205 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 917 | 0.030 |
Why?
| | Prognosis | 1 | 2025 | 4293 | 0.030 |
Why?
| | Disease Susceptibility | 1 | 2018 | 348 | 0.030 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2018 | 220 | 0.030 |
Why?
| | Intra-Abdominal Fat | 1 | 2017 | 100 | 0.030 |
Why?
| | RNA | 1 | 2022 | 940 | 0.030 |
Why?
| | Adult | 2 | 2017 | 40506 | 0.030 |
Why?
| | Macrophages | 1 | 2023 | 1511 | 0.030 |
Why?
| | Keratin-14 | 1 | 2015 | 15 | 0.030 |
Why?
| | Models, Animal | 1 | 2017 | 392 | 0.030 |
Why?
| | Uteroglobin | 1 | 2015 | 30 | 0.030 |
Why?
| | Synchrotrons | 1 | 2014 | 13 | 0.030 |
Why?
| | Mucin 5AC | 1 | 2015 | 70 | 0.030 |
Why?
| | Swine | 1 | 2017 | 833 | 0.030 |
Why?
| | Eating | 1 | 2017 | 392 | 0.030 |
Why?
| | Acetylation | 1 | 2015 | 256 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1718 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 509 | 0.030 |
Why?
| | Wound Healing | 1 | 2017 | 351 | 0.030 |
Why?
| | Forkhead Transcription Factors | 1 | 2015 | 202 | 0.030 |
Why?
| | Tubulin | 1 | 2015 | 147 | 0.020 |
Why?
| | Metabolome | 1 | 2017 | 384 | 0.020 |
Why?
| | Hexanones | 1 | 2013 | 2 | 0.020 |
Why?
| | Daunorubicin | 1 | 2013 | 25 | 0.020 |
Why?
| | Naphthoquinones | 1 | 2013 | 19 | 0.020 |
Why?
| | Mice, Nude | 1 | 2014 | 688 | 0.020 |
Why?
| | Hep G2 Cells | 1 | 2012 | 75 | 0.020 |
Why?
| | Luciferases | 1 | 2012 | 152 | 0.020 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 152 | 0.020 |
Why?
| | Cortisone | 1 | 2011 | 16 | 0.020 |
Why?
| | Microsomes | 1 | 2011 | 33 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 276 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2014 | 1253 | 0.020 |
Why?
| | Enzyme Assays | 1 | 2011 | 25 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 269 | 0.020 |
Why?
| | Hepatocytes | 1 | 2012 | 224 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2882 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2018 | 1786 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2018 | 2499 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2014 | 781 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2011 | 1048 | 0.020 |
Why?
| | Rats | 1 | 2018 | 5614 | 0.020 |
Why?
| | Kinetics | 1 | 2013 | 1629 | 0.020 |
Why?
| | Binding Sites | 1 | 2012 | 1331 | 0.020 |
Why?
| | Base Sequence | 1 | 2012 | 2191 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2013 | 2157 | 0.020 |
Why?
| | Pyridines | 1 | 2013 | 605 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2013 | 2931 | 0.020 |
Why?
| | Liver | 1 | 2017 | 1888 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2017 | 1796 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 8279 | 0.010 |
Why?
| | Placenta | 1 | 2011 | 780 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2012 | 3550 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 7191 | 0.010 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2011 | 2584 | 0.010 |
Why?
|
|
Staab-Weijnitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|